Corporate News 10-Feb-23
Board of Natco Pharma recommends Third Interim Dividend
Of Rs.1.25 per share
Natco Pharma announced that the Board of Directors of the Company at its meeting held on 9 February 2023, has recommended a Third Interim dividend of Rs.1.25 per share (i.e.62.50%), subject to the approval of the shareholders.
Previous News
Natco Pharma consolidated net profit rises 59.05% in the June 2024 quarter
( Results - Announcements 12-Aug-24 15:07 )
Natco Pharma
( Results - Analysis 15-Feb-24 10:36 )
Board of Natco Pharma recommends dividend
( Corporate News - 12-Aug-24 15:57 )
Natco Pharma spurts as Q1 PAT climbs 59% YoY to Rs 668 cr
( Hot Pursuit - 12-Aug-24 15:13 )
Natco Pharma
( Results - Analysis 11-Nov-22 16:31 )
Natco Pharma to conduct board meeting
( Corporate News - 01-Nov-22 12:10 )
Natco Pharma
( Results - Analysis 10-Feb-23 10:47 )
Natco Pharma allots 1.55 lakh equity shares under ESOP
( Corporate News - 28-Jan-22 18:44 )
US Appeals Court rejects Alvogen's appeal on Ibrutinib Tablets
( Corporate News - 16-Nov-22 09:47 )
Natco Pharma forays into pheromone based technology for integrated pest management
( Hot Pursuit - 15-Mar-21 13:11 )
Natco Pharma Ltd leads gainers in 'A' group
( Hot Pursuit - 16-Feb-24 12:00 )
Other Stories
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Astec LifeSciences director resigns
04-Oct-24 19:08
Board of Gravita India approves change in directorate
04-Oct-24 19:05
Board of Gravita India approves fund raising up to Rs 1,000 cr
04-Oct-24 19:03
Back
Top
